Hemorrhage clinical trials at UC Davis

• A Study of Testing Tranexamic Acid After Traumatic Injury in Children

  open to eligible people ages up to 17 years

  Trauma is the leading cause of death and disability in children in the United States. The long-term goal of this project is to evaluate the benefits and harms of tranexamic acid (TXA; a drug that stops bleeding) in severely injured children. This is a 40-patient pilot study to evaluate the feasibility of two subsequent large-scale studies of TXA in injured children.

  Sacramento, California and other locations

Last updated: September 1, 2021